Conditions

Macular Degeneration / AMD

As a person ages, their vision can deteriorate over time. One of the most common causes of vision loss in older adults is age-related macular degeneration (AMD).

AMD occurs when the macular cells deteriorate and cease to function properly. The macula is the central area of the retina that controls our central vision; it’s used for fine-detail activities such as driving, facial recognition, reading, and recognizing color. As macular degeneration progresses, it can make objects in your line of vision appear distorted. Patients with AMD may also experience clouded vision or a layer of darkness over the central visual field. Eventually, patients may lose the ability to see details, which can impair normal daily activities. AMD is categorized into two different types: wet and dry AMD.

Fortunately, because macular conditions like AMD impact only the macula, the rest of the retina typically remains unaffected, keeping peripheral vision intact. As such, AMD rarely results in total vision loss.

What is dry age-related macular degeneration?

The most common type of macular degeneration is dry AMD. In dry AMD, the macular cells gradually reduce in number and become less sensitive. Vision loss tends to occur slowly over time, with cases ranging from mild to severe.

Typically, an ophthalmologist will note the presence of drusen, which are yellow deposits of debris that build up under the macula. Drusen are normally seen in patients aged 50 and older. While drusen deposits are not responsible for vision loss alone, their presence signifies a greater risk for developing macular issues in the future.

What is wet age-related macular degeneration?

Dry AMD sometimes progresses into wet AMD, which is characterized by the growth of abnormal blood vessels that leak fluid or bleed into the macula. If left untreated, wet AMD can cause permanent loss of central vision. Unlike dry AMD which happens over time, the onset of wet AMD can happen suddenly and result in a severe decline in vision.

AMD Symptoms

AMD may present with no symptoms at first, especially dry AMD. As time goes on, you may experience several changes in vision, such as:

  • Blurriness
  • Straight lines appearing wavy and other distortions
  • Missing areas of vision
  • Clouded or darkened vision
  • Difficulty performing fine-detail activities, such as reading

AMD Risk Factors

There are several risk factors that can increase a patient’s chance of developing macular degeneration. These risk factors include:

  • Age
  • Genetics
  • Tobacco use
  • Obesity
  • High-fat diet
  • High cholesterol
  • High blood pressure
  • Cardiovascular diseases, such as atherosclerosis

Can AMD be prevented?

Because macular degeneration is so closely linked to aging, prevention recommendations normally involve a healthy diet, weight management, cutting out tobacco use, and protecting your eyes from the sun’s harmful UV rays. Some studies of AMD have shown that patients who include antioxidant vitamins and minerals in their daily routine have a lower risk of developing severe vision loss. These recommended vitamins and dosages include:

  • Vitamin C, 500 mg
  • Vitamin E, 400 IU
  • Lutein, 10mg
  • Zeaxanthin, 2mg
  • Zinc, 80mg
  • Copper, 2mg

Please connect with your doctor directly per advice for supplement use, including type(s) and dosage to best ensure healthy vision.

AMD Treatment

Treatment for dry AMD typically consists of preventative measures and vitamin usage. In cases of wet AMD, your doctor will recommend treatment depending on the severity of your symptoms. When wet AMD is detected early the current treatments give a reasonable chance to recover vision in many patients thus emphasizing the importance of early detection strategies. These treatments include intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) medications and laser treatments. Although vision loss from wet AMD is typically permanent, early detection and treatment can often provide an optimal outcome.

While there is currently no cure, AMD is one of the most researched retinal conditions, with many clinical trials dedicated to developing new and improved treatments.